France – Services de recherche et développement expérimental – Études précliniques d'un candidat-médicament antigrippal

DeadlineJune 19, 2026 at 02:00 PM29 days left

AI summary

This tender concerns preclinical studies of an experimental antiflu drug candidate. The University of Tours seeks to contract research and development services to evaluate the pharmacological properties, safety, and efficacy of a potential influenza treatment before human clinical trials.

#preclinical research#drug development#antiviral#r&d services#pharmaceutical#tours#france
Fit for

Biomedical research organizations, contract research organizations (CROs), pharmaceutical research institutions, or academic laboratories with accredited preclinical research facilities and relevant expertise should bid.

Key requirements

Suppliers must have expertise in preclinical research methodologies, including in vitro and in vivo testing, pharmacology, and toxicology. Experience with antiviral drug development and regulatory compliance for pharmaceutical research is essential.

Frequently asked questions

  • What is this tender about?

    This tender concerns preclinical studies of an experimental antiflu drug candidate. The University of Tours seeks to contract research and development services to evaluate the pharmacological properties, safety, and efficacy of a potential influenza treatment before human clinical trials.

  • What are the requirements for suppliers?

    Suppliers must have expertise in preclinical research methodologies, including in vitro and in vivo testing, pharmacology, and toxicology. Experience with antiviral drug development and regulatory compliance for pharmaceutical research is essential.

  • What type of company should bid?

    Biomedical research organizations, contract research organizations (CROs), pharmaceutical research institutions, or academic laboratories with accredited preclinical research facilities and relevant expertise should bid.

  • Who is the buyer?

    The buyer is Université de Tours.

  • When does this tender close?

    Submissions close on June 19, 2026.

  • What is the estimated value?

    The estimated value is 0 EUR.

Études précliniques d'un candidat-médicament antigrippal

Buyer
Université de Tours
Buyer ID: 19370800500478·Philippe ROINGEARD
60 rue du Plat d’Etain, 37020, Tours Cedex 1
Body responsible for review procedures
Tribunal administratif d’Orléans
Buyer ID: 17450005800022
28 rue de la Bretonnerie, 45057, Orléans Cedex 1
Other organization
Médiateur des entreprises en région Centre-Val de Loire
Buyer ID: 23450002300028
9 rue Saint-Pierre Lentin, 45041, ORLÉANS Cedex 1

Computing match…

AI document analysis

We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.

Loading…